Arrowstreet Capital’s Sensus Healthcare SRTS Stock Holding History

Arrowstreet Capital’s Portfolio SRTS Stock Details SRTS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-150,150	Closed	-$1.04M	–	2006
2024 Q4	$1.04M	Buy	150,150 +67,269	+81%	+$493K	﹤0.01%	1441
2024 Q3	$481K	Buy	82,881 +6,742	+9%	+$40.9K	﹤0.01%	1520
2024 Q2	$406K	Buy	+76,139	New	+$350K	﹤0.01%	1363
2023 Q3	–	Sell	-18,182	Closed	-$57K	–	1413
2023 Q2	$57K	Sell	18,182 -21,796	-55%	-$78.7K	﹤0.01%	1188
2023 Q1	$208K	Sell	39,978 -22,950	-36%	-$165K	﹤0.01%	1291
2022 Q4	$467K	Sell	62,928 -33,991	-35%	-$307K	﹤0.01%	1143
2022 Q3	$1.21M	Buy	96,919 +24,681	+34%	+$295K	﹤0.01%	962
2022 Q2	$555K	Buy	72,238 +44,072	+156%	+$370K	﹤0.01%	1053
2022 Q1	$285K	Buy	+28,166	New	+$257K	﹤0.01%	1080

Other funds holding SRTS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

PCM

Perritt Capital Management Chicago, Illinois $59.8M AUM 26.94% 1-Year Est. Return

Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

PRCP

Pacific Ridge Capital Partners Lake Oswego, Oregon $462M AUM 40.76% 1-Year Est. Return

Arrowstreet Capital's SRTS Position: Q1 2025 in Review

Arrowstreet Capital sold out of Sensus Healthcare (SRTS) in Q1 2025, closing a stake of 150,150 shares — an estimated $1.04M sold.

Arrowstreet Capital first reported a position in SRTS in Q1 2022 and held it in 9 quarters. The position peaked at $1.21M in Q3 2022. 53 funds tracked by Wall St. Rank hold SRTS as of Q1 2025.

Arrowstreet Capital reported no remaining Sensus Healthcare position as of Q1 2025 after selling out during the quarter.
Arrowstreet Capital sold 150,150 Sensus Healthcare shares in Q1 2025, an estimated $1.04M.
Arrowstreet Capital first reported a position in Sensus Healthcare in Q1 2022 and held it in 9 quarters.
Arrowstreet Capital's Sensus Healthcare position peaked at $1.21M in Q3 2022.
53 funds tracked by Wall St. Rank held Sensus Healthcare as of Q1 2025.

Based on Arrowstreet Capital's 13F filing for Q1 2025, filed 14 May 2025.